The paradox of non-adherence to treatment in oncology
This video is a recording of a session from a:care congress 2022.
The progress of medicine and oncological treatments has significantly improved chances of survival for numerous types of cancer. Professor Enrique De Madaria explains how the increased efficacy of treatment associated with improvements in galenic formulations has led to a change of paradigm for cancer: from a progressive, fatal condition to a chronic disease. However, this medical success is dampened by the frequency of treatment non-adherence in oncology – a challenge that can be explained by multiple oncology-specific factors.
To better understand the potential causes of non-adherence specific to patients with cancer, watch the video.
Speakers
PROF.
ENRIQUE DE MADARIA
Spain
